# Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

> **NCT07199179** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 456 (actual)

## Conditions studied

- Depression - Major Depressive Disorder
- Depression Disorder
- Suicide

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07199179
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-24
- **Primary completion:** 2025-11-24
- **Final completion:** 2025-11-24
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199179, "Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07199179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*